Pharmacological and Toxicological Advances in PPAR-Related Medicines

• Pharmacological and Toxicological Advances in PPAR-Related Medicines, Yuji Kamijo, Christopher J. Nicol, and Stefan E. H. Alexson
  Volume 2012 (2012), Article ID 940964, 2 pages
• PPAR Medicines and Human Disease: The ABCs of It All, Anthony J. Apostoli and Christopher J. B. Nicol
  Volume 2012 (2012), Article ID 504918, 16 pages
• The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination, Graham Skelhorne-Gross and Christopher J. B. Nicol
  Volume 2012 (2012), Article ID 946943, 13 pages
• Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated Receptor Less Than That of a Mouse but May Activate Constitutive Androstane Receptor in Liver, Yuki Ito, Toshiki Nakamura, Yukie Yanagiba, Doni Hikmat Ramdhan, Nozomi Yamagishi, Hisao Naito, Michihiro Kamijima, Frank J. Gonzalez, and Tamie Nakajima
  Volume 2012 (2012), Article ID 201284, 11 pages
• Nutraceuticals as Ligands of PPAR , Meera Penumetcha and Nalini Santanam
  Volume 2012 (2012), Article ID 858352, 7 pages
• Idealized PPAR-Based Therapies: Lessons from Bench and Bedside, Angélica Amorim Amato and Francisco de Assis Rocha Neves
  Volume 2012 (2012), Article ID 978687, 9 pages
• Peroxisome Proliferator-Activated Receptor Agonists Differentially Regulate Inhibitor of DNA Binding Expression in Rodents and Human Cells, María del Carmen González, J. Christopher Corton, Nuria Acero, Dolores Muñoz-Mingarro, Yolanda Quirós, Juan José Álvarez-Millán, Emilio Herrera, and Carlos Bocos
  Volume 2012 (2012), Article ID 483536, 9 pages
• Effects of PPARγ Ligands on Leukemia, Yoko Tabe, Marina Konopleva, Michael Andreeff, and Akimichi Ohsaka
  Volume 2012 (2012), Article ID 483656, 8 pages
• The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury, M. Elias-Miró, M. B. Jiménez-Castro, M. Mendes-Braz, A. Casillas-Ramírez, and C. Peralta
  Volume 2012 (2012), Article ID 802384, 14 pages
• PPAR Activation Protects against Anti-Thy1 Nephritis by Suppressing Glomerular NF- B Signaling, Koji Hashimoto, Yuji Kamijo, Takero Nakajima, Makoto Harada, Makoto Higuchi, Takashi Ehara, Hidekazu Shigematsu, and Toshifumi Aoyama
  Volume 2012 (2012), Article ID 976089, 11 pages
• Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease, Daisuke Yoshihara, Masanori Kugita, Tamio Yamaguchi, Harold M. Aukema, Hiroki Kurahashi, Miwa Morita, Yoshiyuki Hiki, James P. Calvet, Darren P. Wallace, Takafumi Toyohara, Takaaki Abe, and Shizuko Nagao
  Volume 2012 (2012), Article ID 695898, 10 pages
• Fatty Acid Accumulation and Resulting PPAR Activation in Fibroblasts due to Trifunctional Protein Deficiency, Masato Wakabayashi, Yuji Kamijo, Takero Nakajima, Naoki Tanaka, Eiko Sugiyama, Tian Yangyang, Takefumi Kimura, and Toshifumi Aoyama
  Volume 2012 (2012), Article ID 371691, 7 pages
• Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice, Takefumi Kimura, Takero Nakajima, Yuji Kamijo, Naoki Tanaka, Lixuan Wang, Atsushi Hara, Eiko Sugiyama, Eiji Tanaka, Frank J. Gonzalez, and Toshifumi Aoyama
  Volume 2012 (2012), Article ID 174932, 10 pages